Notably, cancer patients with albumin levels ≤ 4.2 g/dL were characterized by older age, a higher likelihood of being female, a greater propensity for being overweight, and a statistically significant increase in the prevalence of diabetes mellitus, hypertension, cardiovascular disease, and anemia. This evidence concerns the gene ALB and diabetes mellitus.